Gemcitabine-related thrombotic microangiopathy: a single-centre retrospective series

References

• Zupancic M, Shah PC, Shah-Khan F. Gemcitabine-associated thrombotic thrombocytopenic purpura. Lancet Oncol. 2007;8:634–41.
   PubMed Web of Science ®Google Scholar
• Lesesne JB, Rothschild N, Erickson B, Korec S, Sisk R, Keller J, et al. Cancer-associated hemolytic-uremic syndrome: analysis of 85 cases from a national registry. J Clin Oncol. 1989;7:781–9.
   PubMed Web of Science ®Google Scholar
• Sheldon R, Slaughter D. A syndrome of microangiopathic hemolytic anemia, renal impairment, and pulmonary edema in chemotherapy-treated patients with adenocarcinoma. Cancer. 1986;58:1428–36.
   PubMed Web of Science ®Google Scholar
• Izzedine H, Isnard-Bagnis C, Launay-Vacher V, Mercadal L, Tostivint I, Rixie O, et al. Gemcitabine-induced thrombotic microangiopathy: a systematic review. Nephrol Dial Transplant. 2006;21:3038–45.
   PubMed Web of Science ®Google Scholar
• Muller S, Schutt P, Bojko P, Nowrousian MR, Hense J, Seeber S, et al. Hemolytic uremic syndrome following prolonged gemcitabine therapy: report of four cases from a single institution. Ann Hematol. 2005;84:110–4.
   PubMed Web of Science ®Google Scholar
• Murrin RJ, Murray JA. Thrombotic thrombocytopenic purpura: aetiology, pathophysiology and treatment. Blood Rev. 2006;20:51–60.
   PubMed Web of Science ®Google Scholar
• Moake J. Thrombotic thrombocytopenia purpura (TTP) and other thrombotic microangiopathies. Best Pract Res Clin Haematol. 2009;22:567–76.
   PubMed Web of Science ®Google Scholar
• Cantrell JE Jr, Phillips TM, Schein PS. Carcinoma-associated hemolytic-uremic syndrome: a complication of mitomycin C chemotherapy. J Clin Oncol. 1985;3:723–34.
   PubMed Web of Science ®Google Scholar
• Proia AD, Harden EA, Silberman HR. Mitomycin-induced hemolytic-uremic syndrome. Arch Pathol Lab Med. 1984;108:959–62.
   PubMed Web of Science ®Google Scholar
• Watson PR, Guthrie TH Jr, Caruana RJ. Cisplatin-associated hemolytic-uremic syndrome. Successful treatment with a staphylococcal protein A column. Cancer. 1989;64:1400–3.
   PubMed Web of Science ®Google Scholar
• Leach JW, Pham T, Diamandidis D, George JN. Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS) following treatment with deoxycoformycin in a patient with cutaneous T-cell lymphoma (Sezary syndrome): a case report. Am J Hematol. 1999;61:268–70.
   PubMed Web of Science ®Google Scholar
• Snyder HW Jr, Mittelman A, Oral A, Messersschmidt GL, Henry DH, Korec S, et al. Treatment of cancer chemotherapy-associated thrombotic thrombocytopenic purpura/hemolytic uremic syndrome by protein A immunoadsorption of plasma. Cancer. 1993;71:1882–92.
   PubMed Web of Science ®Google Scholar
• Flombaum CD, Mouradian JA, Casper ES, Erlandson RA, Benedetti F. Thrombotic microangiopathy as a complication of long-term therapy with gemcitabine. Am J Kidney Dis. 1999;33:555–62.
   PubMed Web of Science ®Google Scholar
• Porta C, Danova M, Riccardi A, Bobbio-Pallavicini E, Ascari E. Cancer chemotherapy-related thrombotic thrombocytopenic purpura: biological evidence of increased nitric oxide production. Mayo Clin Proc. 1999;74:570–4.
   PubMed Web of Science ®Google Scholar
• Oleksowicz L, Bhagwati N, DeLeon-Fernandez M. Deficient activity of von Willebrand's factor-cleaving protease in patients with disseminated malignancies. Cancer Res. 1999;59:2244–50.
   PubMed Web of Science ®Google Scholar
• Moake JL. Thrombotic microangiopathies. N Engl J Med. 2002;347:589–600.
   PubMed Web of Science ®Google Scholar
• Humphreys BD, Sharman JP, Henderson JM, Clark JW, Marks PW, Rennke HG, et al. Gemcitabine-associated thrombotic microangiopathy. Cancer. 2004;100:2664–70.
   PubMed Web of Science ®Google Scholar
• Lewin SN, Mutch DG, Whitcomb BP, Liapis H, Herzog TJ. Three cases of hemolytic uremic syndrome in ovarian cancer patients treated with combination gemcitabine and pegylated liposomal doxorubicin. Gynecol Oncol. 2005;97:228–33.
   PubMed Web of Science ®Google Scholar
• Fung MC, Storniolo AM, Nguyen B, Arning M, Brookfield W, Vigil J. A review of hemolytic uremic syndrome in patients treated with gemcitabine therapy. Cancer. 1999;85:2023–32.
   PubMed Web of Science ®Google Scholar
• De Smet D, Jochmans K, Neyns B. Development of thrombotic thrombocytopenic purpura after a single dose of gemcitabine. Ann Hematol. 2008;87:495–6.
   PubMed Web of Science ®Google Scholar
• Lyman NW, Michaelson R, Viscuso RL, Winn R, Mulgaonakar S, Jacobs MG. Mitomycin-induced hemolytic-uremic syndrome. Successful treatment with corticosteroids and intense plasma exchange. Arch Intern Med. 1983;143:1617–8.
   PubMedGoogle Scholar
• Gourley BL, Mesa H, Gupta P. Rapid and complete resolution of chemotherapy-induced thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS) with rituximab. Cancer Chemother Pharmacol. 2010;65:1001–4.
   PubMed Web of Science ®Google Scholar
• Ruiz I, Del Valle J, Gomez A. Gemcitabine and haemolytic-uraemic syndrome. Ann Oncol. 2004;15:1575–6.
   PubMed Web of Science ®Google Scholar
• Pfister C. Muller S, Schutt P, Bojko P, Nowrousian MR, Hense J, Seeber S, Ann MoritzT.. Hemolytic uremic syndrome following prolonged gemcitabine therapy: report of four cases from a single institution. Hematol. 2005;84(2):110–4. [Ann Hematol. 2005;84:621–2].
   Web of Science ®Google Scholar
• Citarrella P, Gebbia V, Teresi M, Miceli S, Sciortino G, Vaglica M, et al. Hemolytic uremic syndrome after chemotherapy with gemcitabine and taxotere: a case report. Anticancer Res. 2002;22:1183–5.
   PubMed Web of Science ®Google Scholar
• Kasi PM. Thrombotic thrombocytopenic purpura and gemcitabine. Case Rep Oncol. 2011;4(1):143–8.
   PubMedGoogle Scholar
• Graas MP, Houbiers G, Demolin G, Stultiens A, Focan C. Hemolytic uremic syndrome Induced bygemcitabine. A poorly recognized complication? Rev Med Liege. 2012;67(12):644–8.
   PubMedGoogle Scholar
• Zemtsov A, Omueti-Ayoade K, Zemtsov R, Yang M. Livedo reticularis as an initial clinical manifestation of gemcitabine-induced hemolytic uremic syndrome. J Dermatol. 2012;39(5):487–9.
   PubMed Web of Science ®Google Scholar